CONTEXT AND OBJECTIVE: Clinical trial registration is a prerequisite for publication in respected scientific journals. Recent Brazilian regulations also require registration of some clinical trials in the Brazilian Clinical Trials Registry (ReBEC) but there is little information available about practical issues involved in the registration process. This article discusses the importance of clinical trial registration and the practical issues involved in this process. DESIGN AND SETTING: Descriptive study conducted by researchers within a postgraduate program at a public university in São Paulo, Brazil. METHODS: Information was obtained from clinical trial registry platforms, article reference lists and websites (last search: September 2014) on the following topics: definition of a clinical trial, history, purpose and importance of registry platforms, the information that should be registered and the registration process.
INTRODUCTION
Registration of clinical trials has received increasing attention over the last few years. Discussions have progressed from theoretical issues, such as the importance of establishing trial registration platforms 1 and the creation of these registries, to regulatory issues involving enforcement of trial registration, such as through publication and legal restraints. [2] [3] [4] [5] [6] Many published papers on the history of trial registries are available at the Ottawa Group website, 7 including the 2004 Ottawa Statement, which presents the main principles for development of these registries. 8 Over the last 14 years, the Brazilian government has recognized the strategic importance of scientific research for the country and has created mechanisms and structures to administer and encourage research. [9] [10] [11] In consonance with this plan, the Brazilian Clinical Trials Registry (ReBEC) has been created to register and provide information on clinical trials conducted in Brazil. 12 Previous published papers have analyzed the importance of trial registries in general and of the ReBEC platform in particular for Brazilian researchers. [12] [13] [14] However, to the best of our knowledge, no previous papers have assessed the recent changes in the regulatory scenario of trial registries or provided any practical guidance for Brazilian researchers on how to register their trials.
This gap motivated us to write this paper, which presents theoretical and practical issues relating to trial registration in Brazil.
OBJECTIVES
This study aimed to inform Brazilian researchers about the history and importance of clinical trial registration and to offer practical advice on how to use the ReBEC platform.
METHODS
This was a descriptive study. We searched MEDLINE (via PubMed), SciELO and LILACS from inception to September 30, 2014, for information on clinical trial registration, using the plain text "randomized controlled trial", OR "registry databases" OR "randomized controlled trial registration" and their corresponding Brazilian terms "Ensaio Clínico Controlado Aleatório", "Bases From these sources, we extracted information on 1) the definition of a trial, 2) the history and importance of trial registries and 3) details on where, when and how Brazilian researchers can register their trials.
RESULTS

What is a trial?
A trial is a study that prospectively assigns human beings or groups of human beings to one health-related intervention or to a series of such interventions, in order to assess the effects of the interventions on health. 15 
History and importance of trial registries
Before conducting a trial, researchers usually write a protocol that provides a brief contextual description of the problem or disease that will be investigated, the specific research question, the objectives of their study and some details on the methods that will be used, such as the participant selection criteria, a description of the intervention and the exact outcomes that will be assessed, as well as statistical issues such as sample size calculation and how the data will be analyzed. 20 Although this study protocol is naturally written by all investigators prior to actually beginning their study, until recently it was not mandatory to publish or register this protocol anywhere.
Registration of a trial protocol is an ethical pledge to ensure transparency in the execution and publication of studies. 3, 6, 8, 12, 13, 15, 21 WHO highlights that trial registries can also be sources of evidence on the efficacy and safety of health interventions. 22 The main reasons for clinical trial registration are: a) To avoid publication bias. 3, 8, [13] [14] [15] Registration of a trial protocol, in theory, ensures that the results of that study will be published, regardless of whether the findings were beneficial, harmful, inconclusive or even inefficacious.
b) To avoid selective reporting. 3, 8, [13] [14] [15] Registration of all essential details about outcomes that will be analyzed in the study protocol will preclude authors from selecting which outcome data will later be published.
c) To honor the ethical participant-investigator covenant. 3, 8, [12] [13] [14] [15] In theory, registration of a trial ensures that both the methods and the results of the study will be published. Through publishing the study, the investigators will fulfill their ethical responsibility to the participants, because the data gathered in the study will be used to advance scientific knowledge. To meet the publication requirements of the ICMJE, the trial protocol must be registered in one of the primary registries of the ICTRP network. 15 12, 17 protocol amendments also become public. 34 Before registering the trial protocol, the authors need to have obtained approval for their study through local or national ethics committees. The real recruitment of participants should only begin after the trial registration has been officially completed and is available online, since registration is not accepted after that point. 6, 14 Clinical trials not registered from inception will face difficulties in the publishing process, since they will not be accepted by ICMJE-affiliated and probably many other journals.
The key elements needed for registering trials on these platforms are very simple and are usually part of any study protocol.
Box 1 describes key data required for registering a trial in the
WHO network (ICTRP) of affiliated platforms.
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Practical advice on registration in ReBEC
Registration of a trial on the Brazilian platform follows steps that are similar to those of other trial registries. Details and answers to frequently asked questions are provided on the ReBEC website. 6 We should nevertheless point out some inconvenient features of ReBEC, such as the need to fill out many free-text fields (Figure 1) . Another problem is that the instructions on how to The reason for this delay may be that the ClinicalTrials.gov registration form, unlike that of ReBEC, has an interface with many closed questions, which probably speeds up the registration process. Not only that, since 2014 and until now (April 15) the homepage of ReBEC displays a message of staff shortage, which leads us to think that the registration process will be even slower.
DISCUSSION
This study describes the history and importance of clinical trial registry platforms and provides useful information for Brazilian researchers on where and how to register their trials. This pragmatic approach is one of the strengths of the study, since it responds to the needs of researchers who are usually not interested in extensive scientific discussions about clinical trial registration or specific characteristics of some registries but want practical information on this essential topic. 3, 8, [12] [13] [14] 21 This need influenced our search strategy, which was not restricted to scientific articles, but included searches on relevant websites, along with a practical exercise on the Brazilian platform.
Registration of clinical trials emerged from scientific and ethical concerns on research transparency and is now going through a process of scientific and legal regulation aimed at enforcing its implementation.
We recommend that before selecting a specific platform for trial registration, researchers should pay attention to national regulations and laws, which may vary depending on their geographical setting. For Brazilian researchers, or foreign investigators conducting clinical trials in Brazil, the ReBEC platform is an option. ReBEC meets the requirements for publication both in Brazilian and in foreign journals and, in some cases (e.g. for registration of new drugs on the Brazilian market), it is mandatory to register trials on this platform. However, ReBEC has several shortcomings because of its format, and this can considerably delay the process of trial registration. We think that many of the problems identified in ReBEC are probably due to the fact that this registry and the regulations on trial registration are relatively new in Brazil.
However, recent information regarding staff shortages at ReBEC means that improvement in its performance will not happen over the short term, which is highly detrimental to the reputation of the platform and also an impediment for companies that aim to register new drugs in Brazil.
CONCLUSIONS
Clinical trial registration has over 50 years of history and has received increasing attention over the last decade. Brazil has had a national trial registry (ReBEC) since 2010 and regulations have been created to encourage its use. However, this platform has some drawbacks. Researchers should take into account national laws and publication requirements when choosing the platform on which they will register their trial.
